Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for retinopathy of prematurity in newborns: pilot randomized study
2010-018737-21Phase 2Active
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of propranolol in retinopathy of prematurity (ROP) (2 arms), sponsored by Meyer Children's Hospital IRCCS. Primary endpoint: Number of newborns with ROP pre-threshold, threshold and Stage IV. Started Apr 2010; status: active.
02
Drugs
propranolol
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on 2010-018737-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018737-21.